$SNEX

Dunaway William J sold $6.4M of SNEX

Dunaway William J (Chief Financial Officer) sold 96,490 shares of StoneX Group Inc. (SNEX) at $66.35 ($6.40M total) on 2026-08-14 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Dunaway William J
Published Aug 18, 2026, 12:28 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 18, 2026, 12:35 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$SNEX
Neutral
medium confidence
Mentioned
$SNEX
Relevance
5/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$SNEXNeutralLow
01

Why it matters

The newest fact is the disclosed sale details: 96,490 shares at $66.3468 on Aug 14, totaling $6.40M, with holdings after the trade of 502,203 shares.

02

Market read

Traders may treat this as a mild sentiment datapoint, but it does not provide new operational or financial guidance.

03

What to watch

The article does not state whether other insiders sold, whether the plan is part of routine diversification, or whether there were concurrent corporate events.

Relevance 5/10Novelty 3/10Timing: Form 4 filed Aug 17, covering an Aug 14 sale.

Background

The article is a SEC Form 4 insider transaction disclosure for StoneX Group Inc. (SNEX).

Company-level read

Ticker impact

$SNEXNeutralMedium confidence
Context

StoneX CFO Dunaway William J sold 96,490 shares in an open-market transaction worth about $6.40M, per a new Form 4 filed Aug 17.

Expected impact

Likely limited near-term impact; any effect would be sentiment-driven rather than earnings or guidance-related.

Evidence & confidence

The filing discloses transaction size, price, and that it was pre-arranged under Rule 10b5-1, which typically reduces interpretive weight versus discretionary selling.

Market effects

No direct sector read-through; this is company-specific insider activity.

None indicated.

None indicated.

Counterpoint

Even with a 10b5-1 plan, large insider sales can still coincide with private views on near-term risk, so traders may watch for follow-on disclosures.

Key entities

  • StoneX Group Inc.

    Subject of the Form 4 insider transaction disclosure (SNEX).

  • Dunaway William J

    Chief Financial Officer who executed the open-market sale under a Rule 10b5-1 plan.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$WGOMedAI 8/10

Winnebago stock rises as StoneX lowers price target on industry outlook

StoneX lowered its price target on Winnebago (WGO) to $36 from $40, maintaining a Buy rating. The stock trades at $26.83 with a 5.62% dividend yield. Winnebago issued fiscal 2027 guidance for sales of $2.65B-$2.80B and adjusted EPS of $1.65-$2.25, with midpoints above consensus. The company reduced 2026 RV shipment expectations and guided 2027 shipments to 265,000-295,000 units. The stock rose 10.5% on Monday following earnings and guidance.

$MXLMed

MaxLinear stock rating reiterated at Buy by StoneX ahead of results

StoneX reiterated a Buy rating on MaxLinear (MXL) with a $125 price target ahead of its October 22 earnings report. The firm expects Q3 revenue of $215M-$220M, matching consensus. MXL shares are down 20% in a week but up 320% year-to-date. S&P upgraded its outlook to positive, citing strong infrastructure revenue growth. Analysts highlight MXL's potential in the optical market.

$EQBKMed

StoneX lowers Equity Bancshares stock price target on NIM outlook

StoneX reduced its price target for Equity Bancshares (EQBK) to $58 from $59, citing net interest margin expectations. The firm raised its fiscal 2026 EPS forecast to $5.18 but lowered the 2027 estimate to $5.27. EQBK's stock trades at a P/E ratio of 10.58, and analysts expect net income growth. The company recently reported Q3 earnings beating estimates, with EPS of $1.40 vs. $1.29 expected, but revenue missed slightly.